UK HIV/AIDS Diagnostic Testing Market 2015 - With the Market Segmented into Hospitals, Commercial/Private Labs and Blood Banks

News provided by

Research and Markets

27 Oct, 2015, 12:10 ET

DUBLIN, Oct. 27, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/ktzcbp/2015_uk_hivaids) has announced the addition of the "2015 UK HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts" report to their offering.

'2015 UK HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts'

This DataPack presents UK test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot, and other confirmatory assays performed in the following market segments:

  • Hospitals
  • Commercial/Private Labs
  • Blood Banks

Companies Mentioned

  • Abbott
  • Biotest
  • bioMerieux
  • Bio-Rad
  • Grifols
  • Ortho Clinical Diagnostics/J&J
  • Roche
  • Siemens

For more information visit http://www.researchandmarkets.com/research/ktzcbp/2015_uk_hivaids

Media Contact: Laura Wood , +353-1-481-1716, [email protected]

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Also from this source

Cardiovascular Crisis Meets Cutting-Edge Solutions: Insights from the Peripheral Vascular Stents Market Report

Pioneering the Agri-Tech Revolution: FaaS Market Poised for Exponential Growth Through 2032

Explore

More news releases in similar topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.